Roland Martin
Zitiert von
Zitiert von
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
Immunology of multiple sclerosis
M Sospedra, R Martin
Annu. Rev. Immunol. 23 (1), 683-747, 2005
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
Immunological aspects of demyelinating diseases
R Martin, HF McFarland, DE McFarlin
Annual review of immunology 10 (1), 153-187, 1992
Multiple sclerosis: a complicated picture of autoimmunity
HF McFarland, R Martin
Nature immunology 8 (9), 913-919, 2007
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand
B Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ...
Nature medicine 6 (10), 1167-1175, 2000
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ...
Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 2006
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
R Martin, HF McFarland, JM Boggs
Critical reviews in clinical laboratory sciences 32 (2), 121-182, 1995
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways
I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain
Nature immunology 4 (3), 248-254, 2003
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
PA Muraro, DC Douek, A Packer, K Chung, FJ Guenaga, ...
The Journal of experimental medicine 201 (5), 805-816, 2005
The OSCAR-IB consensus criteria for retinal OCT quality assessment
P Tewarie, L Balk, F Costello, A Green, R Martin, S Schippling, A Petzold
PloS one 7 (4), e34823, 2012
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
HF McFarland, JA Frank, PS Albert, ME Smith, R Martin, JO Harris, ...
Annals of neurology 32 (6), 758-766, 1992
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
M Prinz, H Schmidt, A Mildner, KP Knobeloch, UK Hanisch, J Raasch, ...
Immunity 28 (5), 675-686, 2008
Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis
I Jelcic, F Al Nimer, J Wang, V Lentsch, R Planas, I Jelcic, A Madjovski, ...
Cell 175 (1), 85-100. e23, 2018
Exploring the origins of grey matter damage in multiple sclerosis
M Calabrese, R Magliozzi, O Ciccarelli, JJG Geurts, R Reynolds, R Martin
Nature Reviews Neuroscience 16 (3), 147-158, 2015
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ...
Nature 379 (6563), 343-346, 1996
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
N Sommer, PA Löschmann, GH Northoff, M Weller, A Steinbrecher, ...
Nature medicine 1 (3), 244-248, 1995
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
R Martin, D Jaraquemada, M Flerlage, J Richert, J Whitaker, EO Long, ...
Journal of immunology (Baltimore, Md.: 1950) 145 (2), 540-548, 1990
Development of biomarkers in multiple sclerosis
B Bielekova, R Martin
Brain 127 (7), 1463-1478, 2004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20